Developing gene editing therapies based on CRISPR/Cas9 technology.
Industry: Health Care
First Day Return: +13.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/04/2016 |
Offer Price | $16.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 5.9 |
Deal Size ($mm) | $94 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/02/2016 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $94 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 2013 |
Employees at IPO | 55 |
Website www.editasmedicine.com |